2. Gene
  3. C9 - complement C9 Gene

C9 - complement C9 Gene

  • Gene
  • Protein
  • Agent
  • Ortholog
Rattus norvegicus
Gene ID: 117512 | Gene type: protein coding

About C9

Summary

Involved in blood coagulation. Predicted to be located in extracellular space and plasma membrane. Predicted to be part of membrane attack complex. Biomarker of polycystic kidney disease. Human ortholog(s) of this gene implicated in age related macular degeneration 15 and complement component 9 deficiency. Orthologous to human C9 (complement C9). [provided by Alliance of Genome Resources, Apr 2022]

C9 Products(1)

mRNA Protein Name
NM_057146.2 NP_476487.2 complement component C9
Protein Preferred Names Protein Names

complement component C9

complement component 9

Related Agents

Approval
Bioactive Molecules (8)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-17356 Fenofibrate 99.97% Yes
HY-N6972 Cepharanthine 99.87% Yes
HY-B1218 Sulfaphenazole Inhibitor 99.85% Unkown
HY-B0258 Gemfibrozil 99.91% Yes
HY-100386 Ticlopidine Inhibitor 99.56% Unkown
HY-13463 Avatrombopag Agonist 99.83% Yes
HY-13463B Avatrombopag hydrochloride Agonist 97.05% Yes
HY-13463A Avatrombopag maleate 99.88% Yes
Clinical Phase
Bioactive Molecules (8)
Cat. No. Product Name Effect
Purity Phase
HY-132581 Tadnersen Inhibitor 90.06% Phase 3
HY-N1201 Apigenin 99.22% Phase 2
HY-106379 Lurosetron Antagonist / Phase 2
HY-15565 APD668 99.73% Phase 1
HY-15566 APD597 Agonist 99.97% Phase 1
HY-12946 BI 653048 Inhibitor 99.84% Phase 1
HY-114415 AWZ1066S Inhibitor 98.64% Phase 1
HY-12946A BI 653048 phosphate Inhibitor / Phase 1
Pre-clinical Phase
Bioactive Molecules (183)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-N0904 Ginsenoside C-K Inhibitor 99.92% Unkown
HY-103661 BI-6C9 Inhibitor 98.47% Unkown
HY-N0043 Ginsenoside Rd Inhibitor 99.88% Unkown
HY-15550 4'-Hydroxy diclofenac 99.70% Unkown
HY-15550S 4'-Hydroxy diclofenac-d4 98.92% Unkown
HY-N0893 Tetrahydrocurcumin 98.96% Unkown
HY-100738 Ubiquitin Isopeptidase Inhibitor I, G5 Inducer ≥98.0% Unkown
HY-N0920 Dihydrokavain Inhibitor 99.94% Unkown
HY-W013268 (S)-(+)-N-3-Benzylnirvanol Inhibitor 99.82% Unkown
HY-153898 rTRD01 Ligand 99.10% Unkown
HY-117026 LKY-047 Inhibitor 99.94% Unkown
HY-148907 CS640 Inhibitor 99.43% Unkown
HY-117389 Homocarbonyltopsentin 99.88% Unkown
HY-139345 (S,R,S)-AHPC-CO-C9-acid Chemical 95.00% Unkown
HY-N0911 Rehmannioside A 99.96% Unkown
HY-N1446S Oleic acid-13C 99.95% Unkown
HY-114759 MS-PPOH Inhibitor 99.05% Unkown
HY-100641 4-Hydroxytolbutamide 99.69% Unkown
HY-14362 GSK-25 Inhibitor 99.68% Unkown
HY-148822 Nampt activator-2 Activator 98.80% Unkown
HY-N0215S10 L-Phenylalanine-13C9 Antagonist 98.09% Unkown
HY-100641S 4-Hydroxytolbutamide-d9 99.29% Unkown
HY-157581 MS39 Degrader 99.89% Unkown
HY-42034 Hydroquinine 99.84% Unkown
HY-B0158S7 Cytidine-13C9 Chemical ≥95.0% Unkown
HY-N0473S3 L-Tyrosine-13C9 99.81% Unkown
HY-N0688 Linderane Inhibitor 99.61% Unkown
HY-132581A Tadnersen sodium Inhibitor 90.06% Unkown
HY-D1422 ER Thermo Yellow 96.91% Unkown
HY-144652 IDO1-IN-19 Inhibitor 98.52% Unkown
HY-17356R Fenofibrate (Standard) 99.91% Unkown
HY-N0215S11 L-Phenylalanine-13C9,15N Antagonist 99.52% Unkown
HY-128859 EMT inhibitor-2 Inhibitor 98.83% Unkown
HY-113359AS2 Uridine 5'-diphosphate-13C9,15N2 dilithium Agonist 99.5% Unkown
HY-18063 ML252 Inhibitor 99.9% Unkown
HY-N1201R Apigenin (Standard) / Unkown
HY-W751165 Uridine-13C9,15N2 ≥99.0% Unkown
HY-116862 Dibenzylfluorescein 99.54% Unkown
HY-W013175S2 Uridine 5'-monophosphate-13C9,15N2 disodium Activator ≥99.0% Unkown
HY-B0258S Gemfibrozil-d6 98.00% Unkown
HY-107372S Uridine triphosphate-13C9,15N2 sodium / Unkown
HY-107372S2 Uridine triphosphate-13C9 dilithium ≥98.0% Unkown
HY-124352 2-Nonyl-3-hydroxy-4-quinolone ≥98.0% Unkown
HY-125818S3 Cytidine-5'-triphosphate-13C9 dilithium 99.0% Unkown
HY-N1201S Apigenin-d5 98.90% Unkown
HY-N7057S3 Nonanoic acid-d2 98.63% Unkown
HY-N8382 Chalepensin Inhibitor ≥98.0% Unkown
HY-Y0123S DL-Tyrosine-13C9,15N ≥98.0% Unkown
HY-N11222 Nonanoylcarnitine 99.87% Unkown
HY-W009216S1 2'-Deoxycytidine-5'-monophosphate-13C9,15N3 dilithium 99.80% Unkown
HY-131495 (S)-6-O-Desmethylnaproxen Inhibitor 95.73% Unkown
HY-17356S Fenofibrate-d6 99.70% Unkown
HY-B0258R Gemfibrozil (Standard) 99.90% Unkown
HY-D0184S3 2'-Deoxycytidine-13C9,15N3 99.00% Unkown
HY-U00048 Bucolome Inhibitor 98.93% Unkown
HY-W009162S5 Cytidine 5′-monophosphate-13C9,15N3 dilithium 99.80% Unkown
HY-101399S γ-Glu-(Phe-13C9,15N) / Unkown
HY-101399SA γ-Glu-(Phe-13C9,15N) TFA / Unkown
HY-132581E Scrambled Tadnersen Control / Unkown
HY-15550S1 4'-Hydroxy diclofenac-13C6 / Unkown
HY-156159 Thalidomide-NH-C9-NH2 hydrochloride / Unkown
HY-159191S VQPGQN(Phe-13C9,15N)HMFTKEKLEEVIKDI TFA 95.41% Unkown
HY-W018801 5-Nitroisoquinoline 99.38% Unkown
HY-172177 ROCK/HDAC-IN-2 / Unkown
HY-A0070AS1 Liothyronine-13C9,15N / Unkown
HY-135390 Hydroxy desmethyl Bosentan / Unkown
HY-100386S Ticlopidine-d4 Inhibitor / Unkown
HY-101400S2 Deoxycytidine triphosphate-13C9,15N3 dilithium Activator / Unkown
HY-101400S4 Deoxycytidine triphosphate-13C9 dilithium Activator / Unkown
HY-101981S3 Uridine 5'-monophosphate-13C9,15N2 dilithium / Unkown
HY-101981S4 Uridine 5'-monophosphate-13C9 dilithium / Unkown
HY-113359AS1 Uridine 5'-diphosphate-13C9 dilithium Agonist / Unkown
HY-113400S1 Cytidine diphosphate-13C9 dilithium / Unkown
HY-113400S2 Cytidine diphosphate-13C9,15N3 dilithium 99.7% Unkown
HY-113887 Prostaglandin F1β Agonist / Unkown
HY-113887A 11β-Prostaglandin F1β Control / Unkown
HY-116095 CypD-IN-5 Inhibitor / Unkown
HY-116601 6-Hydroxywarfarin / Unkown
HY-119996 AR-C141990 Inhibitor / Unkown
HY-13463BS Avatrombopag-d8 hydrochloride Agonist / Unkown
HY-138517 Thiol-C9-PEG7 / Unkown
HY-138526 Thiol-C9-PEG4-acid / Unkown
HY-138527 Thiol-C9-PEG4 / Unkown
HY-138528 Thiol-C9-PEG5-acid / Unkown
HY-138529 Thiol-C9-PEG5 / Unkown
HY-141547 Nav1.7-IN-8 Inhibitor / Unkown
HY-141878 di-Ellipticine-RIBOTAC Modulator / Unkown
HY-141913S 3-Chlorotyrosine-13C9, 15N hydrochloride / Unkown
HY-143906 URAT1 inhibitor 2 Inhibitor / Unkown
HY-145490 trans-Hydroxy Glimepiride / Unkown
HY-147807 HIV-1 inhibitor-40 Inhibitor / Unkown
HY-148597 FGFR-IN-10 Inhibitor / Unkown
HY-149866 HIV-1 inhibitor-58 Inhibitor / Unkown
HY-150710S Cytidine 5'-triphosphate-13C9,15N3 ammonium / Unkown
HY-151251 CYP2C9/CYP2C19-IN-1 Inhibitor / Unkown
HY-151253 CYP2C1/CYP2C19-IN-2 Inhibitor / Unkown
HY-153371 50-C2-C9-4tail / Unkown
HY-153970 URAT1 inhibitor 7 Inhibitor / Unkown
HY-155265 Pomalidomide-5-C9-NH2 hydrochloride 98.68% Unkown
HY-159143 BChE-IN-33 Inhibitor / Unkown
HY-160555 (S,R,S)-AHPC-CO-C9-NH2 / Unkown
HY-160555A (S,R,S)-AHPC-CO-C9-NH2 hydrochloride 98.79% Unkown
HY-161943 NEU3-IN-1 / Unkown
HY-163208 VH 032 amide-alkylC9-amine hydrochloride / Unkown
HY-163816 Antiproliferative agent-53-d3 Inhibitor / Unkown
HY-166934S Endosulfan-13C9 sulfate / Unkown
HY-167872 Bifeprofen Inhibitor / Unkown
HY-168235 (S,R,S)-AHPC-Me-amide-C9-acid Degrader / Unkown
HY-168277 5-Aminothalidomide-C9-Boc / Unkown
HY-169095 (S,R,S)-AHPC-Me-CO-C9-NH2 / Unkown
HY-171837 c9,t11,c15-CLNA Activator / Unkown
HY-172897 EGFR/DHFR-IN-2 / Unkown
HY-172902 RNA binder 1 / Unkown
HY-173032 VU6033685 Agonist / Unkown
HY-17356G Fenofibrate (GMP) / Unkown
HY-17356S1 Fenofibrate-d4 / Unkown
HY-176737 TGF-β1/Smad-IN-1 Inhibitor / Unkown
HY-177070 Angexostat Inhibitor / Unkown
HY-79131S1 Fmoc-Phe-OH-13C9,15N 99.33% Unkown
HY-B1422S 9-Aminoacridine-13C6 Inhibitor / Unkown
HY-B1449S11 Uridine-13C9 99.00% Unkown
HY-D0184S5 2'-Deoxycytidine-13C9 96.8% Unkown
HY-E70460 Human CYP2C9,Low-Reductase / Unkown
HY-E70473 Human CYP2C9,High-Reductase / Unkown
HY-E70485 Human CYP2C9,High-Reductase+b5 / Unkown
HY-E70486 Human CYP2C9,Low-Reductase +b5 / Unkown
HY-N0043R Ginsenoside Rd (Standard) Inhibitor / Unkown
HY-N0215S9 L-Phenylalanine-13C9,15N,d8 Antagonist / Unkown
HY-N0893S Tetrahydrocurcumin-d6 / Unkown
HY-N0904R Ginsenoside C-K (Standard) Inhibitor / Unkown
HY-N1201S1 Apigenin-13C / Unkown
HY-N6023 Thermopsoside Inhibitor / Unkown
HY-P5538S EPYFGYSGAFK-13C9,15N3 TFA / Unkown
HY-RS00534 AKR1C1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01759 C9 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01760 C9orf72 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01761 C9orf78 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS03460 CYP2C9 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W008849S DMT-dC(bz) Phosphoramidite-13C9,15N3 / Unkown
HY-W009162S1 Cytidine 5′-monophosphate-13C9 dilithium / Unkown
HY-W009216S4 2'-Deoxycytidine-5'-monophosphate-13C9 dilithium / Unkown
HY-W011090S ((2R,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphate-13C9,15N3 sodium / Unkown
HY-W015007S Metyrosine-13C9,15N,d7 Inhibitor / Unkown
HY-W018386AS 3-​Bromo-​L-​tyrosine-13C9,15N TFA / Unkown
HY-W018386S1 3-​Bromo-​L-​tyrosine-13C9 / Unkown
HY-W042357S4 Ac-rC Phosphoramidite-13C9 / Unkown
HY-W042357S6 Ac-rC Phosphoramidite-13C9,15N3 / Unkown
HY-W048482S1 rU Phosphoramidite-13C9,15N2 / Unkown
HY-W048482S2 rU Phosphoramidite-13C9 / Unkown
HY-W127393 N-Nonanoyl-L-homoserine lactone / Unkown
HY-W753181 (S)-2-Hydroxy-3-phenylpropanoic acid-13C9 / Unkown
HY-117160 4-trans-Hydroxy-glibenclamide Inhibitor / Unkown
HY-117925 Personalised postprandial-targeting Inhibitor / Unkown
HY-124209 9-keto Fluprostenol / Unkown
HY-124352S 2-Nonyl-3-hydroxy-4-quinolone-d4 / Unkown
HY-134999 10-Hydroxywarfarin Inhibitor / Unkown
HY-149566 Thalidomide-5-O-C9-NH2 hydrochloride 99.59% Unkown
HY-149572 Thalidomide-4-O-C9-NH2 hydrochloride / Unkown
HY-150712S Uridine triphosphate-13C9,15N2 dilithium / Unkown
HY-156133 Dihydrospinosyn A aglycone / Unkown
HY-164031 Cloperidone Inhibitor / Unkown
HY-169119 Antifungal agent 114 Inhibitor / Unkown
HY-169735 Aurora A inhibitor 4 Inhibitor / Unkown
HY-170367 Antimicrobial agent-35 Inhibitor / Unkown
HY-171836 c9,t11-CLA / Unkown
HY-172335 C9-200 / Unkown
HY-17356S2 Fenofibrate-13C6 / Unkown
HY-175169 Urease-IN-21 Inhibitor / Unkown
HY-18063A ML252 hydrochloride Inhibitor / Unkown
HY-B0158S5 Cytidine-13C9,15N3 / Unkown
HY-B0258S1 Gemfibrozil-d6-1 / Unkown
HY-N12962 11S(12R)-EET / Unkown
HY-N12962A 11R(12S)-EET / Unkown
HY-P0036S3 Octreotide-13C9,15N / Unkown
HY-RS17317 C9 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS20470 Psma4 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS21991 C9orf72 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23772 C9 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W008016S Fmoc-Tyr(tBu)-OH-13C9,15N / Unkown
HY-W440809 Nonyl 8-bromooctanoate / Unkown
HY-W587878 Thujopsene / Unkown
HY-W800740 Nonyl 6-bromohexanoate / Unkown
HY-113623 Pyrenophorol / Unkown
Inhibitory Antibodies (3)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P99141 Anti-Mouse LAG-3 Antibody (C9B7W) Inhibitor 95.00% Unkown
HY-P990140 Anti-Rat β-2-Microglobulin Antibody (4C9) / Unkown
HY-P990204 Anti-Mouse LAG-3 (D265A) Antibody (C9B7W) Inhibitor / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens C9 NCBI NCBI:735
Macaca fascicularis C9 NCBI NCBI:102137382
Mus musculus C9 NCBI NCBI:12279
Leporidae C9 NCBI
Macaca mulatta C9 NCBI NCBI:694223